Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.58 |
| ▸ | ACHE | P22303 | 6/20 | 0.50 |
| ▸ | LMNA | P02545 | 2/20 | 0.47 |
| ▸ | APOBEC3A | P31941 | 1/20 | 0.47 |
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.47 |
| ▸ | TSHR | P16473 | 3/20 | 0.44 |
| ▸ | CHRM5 | P08912 | 2/20 | 0.44 |
| ▸ | CHRM1 | P11229 | 2/20 | 0.44 |
| ▸ | CHRM3 | P20309 | 2/20 | 0.44 |
| ▸ | PGR | P06401 | 1/20 | 0.44 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.44 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.44 |
| ▸ | HTR1A | P08908 | 1/20 | 0.44 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.44 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.44 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.44 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.44 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.44 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2166231 | 1.00 | ALDH1A1 (0.58) | ALDH1A1ACHELMNAAPOBEC3AAPOBEC3G | |
| SCHEMBL28557072 | 1.00 | ALDH1A1 (0.58) | ALDH1A1ACHELMNAAPOBEC3AAPOBEC3G | |
| SCHEMBL1263280 | 1.00 | ALDH1A1 (0.58) | ALDH1A1ACHELMNAAPOBEC3AAPOBEC3G | |
| SCHEMBL6060468 | 1.00 | ALDH1A1 (0.58) | ALDH1A1ACHELMNAAPOBEC3AAPOBEC3G | |
| SCHEMBL11782337 | 1.00 | ALDH1A1 (0.58) | ALDH1A1ACHELMNAAPOBEC3AAPOBEC3G | |
| SCHEMBL6060605 | 1.00 | ALDH1A1 (0.58) | ALDH1A1ACHELMNAAPOBEC3AAPOBEC3G | |
| SCHEMBL6060753 | 1.00 | ALDH1A1 (0.58) | ALDH1A1ACHELMNAAPOBEC3AAPOBEC3G | |
| SCHEMBL20067030 | 1.00 | ALDH1A1 (0.58) | ALDH1A1ACHELMNAAPOBEC3AAPOBEC3G | |
| SCHEMBL763021 | 1.00 | ALDH1A1 (0.58) | ALDH1A1ACHELMNAAPOBEC3AAPOBEC3G | |
| SCHEMBL11781090 | 1.00 | ALDH1A1 (0.58) | ALDH1A1ACHELMNAAPOBEC3AAPOBEC3G |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4739652-A1 | LIPIDS AND COMPOSITIONS THEREOF | Kernal Biologics, Inc. (US) | 2026-05-13 | — | — | EP | disclosed |
| US-20260116845-A1 | LIPIDS AND COMPOSITIONS THEREOF | KERNAL BIOLOGICS INC (US) | 2026-04-30 | — | — | US | disclosed |
| WO-2025010290-A1 | LIPIDS AND COMPOSITIONS THEREOF | KERNAL BIOLOGICS, INC. (US) | 2025-01-09 | — | — | WO | disclosed |
| EP-1706368-A1 | PROCESS FOR PREPARING MONOESTERS | 3M Innovative Properties Company (US) | 2006-10-04 | — | — | EP | disclosed |
| WO-2005066108-A1 | PROCESS FOR PREPARING MONOESTERS | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2005-07-21 | — | — | WO | disclosed |
| US-20050143599-A1 | Process for preparing monoesters | 3M INNOVATIVE PROPERTIES COMPANY | 2005-06-30 | — | — | US | disclosed |
| US-5652247-A | VASOPRESSIN ANTAGONIST | OTSUKA PHARMACEUTICAL CO., LTD (JP) | 1997-07-29 | — | — | US | disclosed |
| US-5436254-A | Vaopressin antagonists | OTSUKA PHARMACEUTICAL COMPANY, LTD. (JP) | 1995-07-25 | — | — | US | disclosed |
| EP-0602209-A1 | OXYTOCIN ANTAGONIST | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1994-06-22 | — | — | EP | disclosed |
| EP-0382185-B1 | Carbostyril derivatives | OTSUKA PHARMA CO LTD (JP) | 1994-06-15 | — | — | EP | disclosed |
| WO-1994001113-A1 | OXYTOCIN ANTAGONIST | OTSUKA PHARMACEUTICAL COMPANY, LIMITED (JP) | 1994-01-20 | — | — | WO | disclosed |
| US-5225402-A | Vasopressin antagonist, vasodilation, hypotensive, diuretics and anticoagulants | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1993-07-06 | — | — | US | disclosed |
| US-4314071-A | ESTERIFYING DICARBOXYLIC ACIDS | BABLER JAMES H | 1982-02-02 | — | — | US | disclosed |
| EP-0020549-A1 | METHOD OF PREPARING MONOESTERS | BABLER, James, H. (US) | 1981-01-07 | — | — | EP | disclosed |
| WO-1980000837-A1 | METHOD OF PREPARING MONOESTERS | BABLER J | 1980-05-01 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050143599-A1 | Process for preparing monoesters | ADSL, COASY, AGPS | ALDH1A1 217/4885ACHE 2406/4885LMNA 1552/4885 |
| US-20260116845-A1 | LIPIDS AND COMPOSITIONS THEREOF | LIPC, LIPA, NPC1L1 | ALDH1A1 2430/4885ACHE 4733/4885LMNA 78/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.